Pharmaceutical companies cannot afford to treat IT compliance as a final checkpoint before deployment. When databases, ERP applications and infrastructure support manufacturing, quality, inventory and supply chain operations, even a small gap in data integrity or system availability can create significant business risks.
Yet many pharmaceutical businesses still operate fragmented IT environments. Critical applications run on isolated servers, databases lack consistent oversight, and infrastructure teams spend considerable time maintaining systems rather than improving them.
The challenge is not simply to keep technology running. It is to build a reliable, secure and traceable environment that supports regulatory requirements while allowing the business to grow.
A Croyant Technologies engagement with a leading pharmaceutical manufacturer demonstrates how the right infrastructure and database architecture can help address these challenges.
Why Does Pharmaceutical IT Infrastructure Need a Compliance-First Approach?
Pharmaceutical companies manage sensitive operational and business data across multiple applications. This includes information related to manufacturing, quality processes, inventory, procurement, finance and reporting.
If these systems operate in disconnected environments, maintaining consistent controls becomes harder.
Common challenges include:
- Data integrity risks: Disconnected systems and inconsistent processes can make it difficult to maintain accurate, reliable information.
- Limited traceability: Inadequate logging and monitoring can make it harder to understand who accessed or changed critical data.
- Availability concerns: Infrastructure failures can interrupt applications that support essential business processes.
- Security gaps: Inconsistent access controls and fragmented infrastructure can increase exposure.
- Rising maintenance costs: Managing multiple isolated environments consumes time and resources.
A compliance-ready IT infrastructure for pharmaceutical companies must address these issues as part of its architecture, not through disconnected corrective measures.
What Should a Compliance-Ready IT Architecture Include?
Compliance requirements vary according to the organisation, its systems and the regulations that apply. However, a well-designed infrastructure should support several essential capabilities.
| Infrastructure capability | Why it matters to pharmaceutical businesses |
| Data integrity controls | Helps protect the accuracy and consistency of critical records |
| Access management | Restricts system and data access according to user responsibilities |
| Auditability and monitoring | Supports visibility into system activity and changes |
| High availability | Reduces disruption when infrastructure components fail |
| Backup and disaster recovery | Supports data protection and operational recovery |
| Secure infrastructure | Helps protect applications, databases and sensitive information |
| Scalable architecture | Accommodates new applications, workloads and business growth |
These capabilities must work together. For example, a database backup strategy is valuable, but it does not replace high availability. Similarly, access controls alone cannot provide complete data integrity assurance.
The architecture needs to address the full lifecycle of business-critical data.
How Croyant Strengthened a Pharmaceutical Manufacturer’s IT Foundation
A leading pharmaceutical manufacturer approached Croyant Technologies with a fragmented IT environment. Its SAP ECC system and multiple line-of-business applications operated across isolated servers.
This created data silos, increased infrastructure complexity and pushed up maintenance costs. The organisation also needed to strengthen compliance while preparing its IT environment for future digital initiatives.
Croyant addressed the challenge through an integrated infrastructure modernisation strategy.
1. Migrating SAP ECC to a Private Cloud
Croyant transitioned the client’s SAP ECC environment to a private cloud using an HPE HANA Appliance and SUSE Linux.
This established a more reliable infrastructure foundation for a business-critical application while reducing dependence on the existing fragmented server environment.
For pharmaceutical organisations, this type of modernisation needs careful planning. The migration strategy must account for application dependencies, database performance, data protection and operational continuity.
Learn more about how to modernize SAP ECC infrastructure
2. Strengthening High Availability and Data Integrity
A compliant infrastructure must also remain resilient when components fail.
Croyant implemented HPE Serviceguard Cluster and SUSE Clustering to strengthen high availability and disaster recovery capabilities. These technologies formed part of the compliance-centric architecture designed to support data integrity and regulatory requirements.
This is particularly important for database environments supporting ERP and other critical applications. Redundancy and failover mechanisms can reduce the impact of infrastructure failures, while appropriate monitoring and recovery procedures help teams respond more effectively.
3. Establishing a Hybrid Cloud Foundation
The manufacturer also needed an architecture that could support future growth.
Croyant established a VMware Cloud Foundation-based hybrid cloud model, creating a foundation for scalable line-of-business applications and future digital initiatives.
The engagement addressed more than an immediate infrastructure issue. It helped consolidate the IT environment, reduce maintenance overhead, improve resource utilisation and strengthen the organisation’s compliance posture.
The case study illustrates how private cloud migration, clustering and hybrid cloud architecture can work together to support pharmaceutical IT modernisation. Read the pharmaceutical infrastructure case study.
Why Database Expertise Is Central to Pharmaceutical Compliance
Infrastructure provides the foundation, but databases hold much of the information that business applications depend on.
A database environment that lacks appropriate performance, security, availability and recovery controls can undermine the wider compliance strategy.
Pharmaceutical businesses should assess their database environments against these practical requirements:
- Database security: Are permissions and privileged access managed consistently?
- Performance: Can databases support critical transactions without avoidable bottlenecks?
- Availability: Are business-critical databases protected against single points of failure?
- Backup and recovery: Are backups monitored and recovery procedures tested?
- Data lifecycle management: Are retention, archival and deletion requirements addressed?
- Monitoring: Can teams identify unusual activity, performance degradation and potential failures?
A robust database strategy also needs to consider the applications connected to each database. Modernising one database without understanding its dependencies can introduce operational risk elsewhere.
This is why database assessment, architecture, migration, managed services and infrastructure planning should form part of a coordinated programme.
What Should Pharmaceutical Companies Evaluate Before Modernising?
Before investing in new infrastructure or database technologies, IT leaders should establish a clear picture of the current environment.
| Assessment question | Business value |
| Which databases support critical applications? | Identifies workloads that need stronger protection |
| Where are data silos affecting operations? | Highlights integration and consolidation opportunities |
| Which systems have availability or recovery gaps? | Helps prioritise resilience improvements |
| Are access and monitoring controls consistent? | Identifies potential governance weaknesses |
| Which workloads are suitable for private or hybrid cloud? | Guides infrastructure decisions |
| Can the current architecture support future growth? | Helps prevent another costly technology redesign |
This assessment helps organisations prioritise modernisation based on business risk rather than technology trends.
Private vs on-premises infrastructure for pharma industry: which is the best?
Build a Stronger Foundation with Croyant Technologies
Building a compliance-ready IT infrastructure for pharmaceutical companies requires expertise across databases, enterprise applications, cloud platforms, high availability and infrastructure management.
Croyant Technologies brings these capabilities together to help businesses address fragmented environments, modernise critical workloads and build resilient IT foundations.
Its pharmaceutical manufacturing engagement demonstrates how a coordinated approach to SAP ECC migration, HPE infrastructure, SUSE clustering and hybrid cloud architecture can address operational complexity while supporting data integrity, availability and future scalability.
For pharmaceutical businesses, the objective should be clear: create an IT environment that supports reliable operations, strengthens control over critical data and provides room for future innovation.
Compliance should influence the architecture from day one. The right database and infrastructure strategy makes that possible.
Explore our modern database management solutions for Pharma businesses.


